GlassScriptPhysician profile
Raja Sabbagh
NPI 1720199151
$12,025.15
in general payments reported to CMS, 2019-2025
14 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,121 · 2020: $316 · 2021: $125 · 2022: $20.96 · 2023: $7,351 · 2024: $2,019 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,500 · Travel and Lodging: $2,658 · Food and Beverage: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,500.00 |
| Travel and Lodging | $2,657.95 |
| Food and Beverage | $1,284.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,265.92 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Medline Industries LP | $779.01 | 2019-2020 | |
| Davol INC. | $772.63 | 2019-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $396.02 | 2019 | |
| Baxter Healthcare | $150.00 | 2025 | Floseal, Tisseel |
| Solventum Corporation | $144.97 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Novo Nordisk INC | $124.38 | 2025 | Wegovy |
| Acell, INC. | $111.32 | 2020 | |
| Becton, Dickinson and Company | $103.87 | 2024 | Phasix Mesh |
| Biotronik INC. | $74.62 | 2021 | |
| Kci USA, INC. | $37.67 | 2021-2022 | |
| Specialty Surgical Instrumentation | $33.27 | 2021 | |
| Z-Medica, LLC | $17.27 | 2019 | |
| Lemaitre Vascular, INC. | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raja Sabbagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.